Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antiemetic Prophylaxis for Chemotherapy-Induced Nausea and Vomiting.

× No keyword cloud information.

106 in total

Review 1. Use of Direct Oral Anticoagulants in Patients with Cancer: Practical Considerations for the Management of Patients with Nausea or Vomiting.

Authors: Hanno Riess; Cihan Ay; Rupert Bauersachs; Cecilia Becattini; Jan Beyer-Westendorf; Francis Cajfinger; Ian Chau; Alexander T Cohen; Alok A Khorana; Anthony Maraveyas; Marcos Renni; Annie M Young
Journal: Oncologist Date: 2018-04-12

Review 2. Acute graft-versus-host disease of the gut: considerations for the gastroenterologist.

Authors: Steven Naymagon; Leonard Naymagon; Serre-Yu Wong; Huaibin Mabel Ko; Anne Renteria; John Levine; Jean-Frederic Colombel; James Ferrara
Journal: Nat Rev Gastroenterol Hepatol Date: 2017-09-27 Impact factor: 46.802

3. Evaluation of antiemetic practices for prevention of chemotherapy-induced nausea and vomiting (CINV): results of a European oncology nurse survey.

Authors: Pascale Dielenseger; Sussanne Börjeson; Cheryl Vidall; Annie Young; Patrick Jahn
Journal: Support Care Cancer Date: 2019-02-19 Impact factor: 3.603

Review 4. Antiemetic therapy for non-anthracycline and cyclophosphamide moderately emetogenic chemotherapy.

Authors: Naoki Inui
Journal: Med Oncol Date: 2017-04-01 Impact factor: 3.064

5. Rolapitant (Varubi): A Substance P/Neurokinin-1 Receptor Antagonist for the Prevention of Chemotherapy-Induced Nausea and Vomiting.

Authors: Tamara Goldberg; Brooke Fidler; Stephanie Cardinale
Journal: P T Date: 2017-03

Review 6. Management of Chemotherapy-Induced Nausea and Vomiting in Pediatric Patients.

Authors: Rudolph M Navari
Journal: Paediatr Drugs Date: 2017-06 Impact factor: 3.022

7. Dual action of neurokinin-1 antagonists on Mas-related GPCRs.

Authors: Ehsan Azimi; Vemuri B Reddy; Kai-Ting C Shade; Robert M Anthony; Sebastien Talbot; Paula Juliana Seadi Pereira; Ethan A Lerner
Journal: JCI Insight Date: 2016-10-06

8. A randomized trial of olanzapine versus palonosetron versus infused ondansetron for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients undergoing hematopoietic stem cell transplantation.

Authors: Midori Nakagaki; Michael Barras; Cameron Curley; Jason P Butler; Glen A Kennedy
Journal: Support Care Cancer Date: 2016-10-13 Impact factor: 3.603

Review 9. Is the addition of a neurokinin-1 receptor antagonist beneficial in moderately emetogenic chemotherapy?-a systematic review and meta-analysis.

Authors: Karin Jordan; Luisa Blättermann; Axel Hinke; Carsten Müller-Tidow; Franziska Jahn
Journal: Support Care Cancer Date: 2017-08-31 Impact factor: 3.603

Review 10. Unintended Effects of GPCR-Targeted Drugs on the Cancer Phenotype.

Authors: Abigail C Cornwell; Michael E Feigin
Journal: Trends Pharmacol Sci Date: 2020-10-22 Impact factor: 14.819